Age-related differences in the occurrence, severity, and distress of symptoms in older patients at the initiation of chemotherapy

• Published in: BMC geriatrics Vol. 23; no. 1; p. 481
• Main Authors: Johannessen, Marlen Sunde, Miaskowski, Christine, Kleven, Anne Grethe, Ritchie, Christine Seel, Paul, Steven M, Grov, Ellen Karine, Hareide, Martine, Gaudernack, Henrik, Utne, Inger
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 09.08.2023; BioMed Central; BMC
• Subjects: Age; Age groups; Aged patients; Analysis; Blood pressure; Cancer; Cancer therapies; Chemotherapy; Colorectal cancer; Comorbidity; Energy; Evaluation; Geriatrics; Gynecology; Hypertension; Influence; Methods; Older adults; Older people; Oncology; Patients; Questionnaires; Ratings & rankings; Swallowing; Symptom assessment; Symptomatology; Symptoms; Trends; Norway; Chemotherapy; Symptom assessment; Older adults; Symptoms; Cancer
• ISSN: 1471-2318; 1471-2318
• DOI: 10.1186/s12877-023-04198-1

Evaluate for differences in occurrence, severity, and distress ratings for 32 symptoms between younger older adults (YOA, < 70 years) and older adults (OA, ≥ 70 years) at initiation of chemotherapy. Patients (n = 125) were recruited prior to the initiation of chemotherapy and completed the Memorial Symptom Assessment Scale. Differences in occurrence, severity, and distress ratings were evaluated using Independent sample t-tests and Chi-square or Fisher's exact tests. On average, the older patients reported ten concurrent symptoms that equates with a moderate symptom burden. Symptoms with the highest occurrence rates were not always the most severe and/or the most distressing. Few age-related differences were found in patients' symptom experiences. When age-related differences were identified, OA reported lower occurrence, severity, and distress ratings. Nine of the ten symptoms with highest occurrence rates were common for both age groups. For severity and distress, only half of the symptoms were common. In terms of severity and distress, all of the top ten ranked symptoms were in the moderate to severe range. Both YOA and OA reported a moderate symptom burden and severity and distress scores in the moderate to severe range. The symptoms with the highest occurrence rates were not always the most severe/or the most distressing. Our findings suggest that different dimensions of the symptom experience (i.e., occurrence, severity, and distress) warrant evaluation in older oncology patients.